Xun Wang Selected Research

chan su (ChanSu)

1/2020	Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794.
12/2019	The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.
7/2018	Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na+/K+-ATPase α1 subunit.
11/2016	Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xun Wang Research Topics

Disease

67	Neoplasms (Cancer) 02/2023 - 11/2004
19	Inflammation (Inflammations) 01/2022 - 01/2006
13	Hypoxia (Hypoxemia) 02/2023 - 01/2011
11	Glioma (Gliomas) 01/2021 - 01/2017
10	Carcinogenesis 01/2022 - 01/2013
9	Atherosclerosis 01/2022 - 01/2006
8	Infections 07/2022 - 03/2002
8	Glioblastoma (Glioblastoma Multiforme) 02/2021 - 12/2017
7	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 12/2014
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2012
6	Hepatolenticular Degeneration (Wilson's Disease) 01/2021 - 09/2004
6	Mitochondrial Diseases (Mitochondrial Disease) 09/2016 - 01/2014
5	Fibrosis (Cirrhosis) 02/2023 - 11/2009
5	Insulin Resistance 01/2022 - 10/2014
5	Necrosis 08/2017 - 07/2009
4	Non-alcoholic Fatty Liver Disease 09/2022 - 10/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2008
4	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2015
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 07/2003
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2010
4	Ischemia 01/2021 - 08/2011
4	Atrophy 01/2016 - 09/2004
4	Obesity 12/2015 - 04/2010
3	Adenocarcinoma 02/2023 - 08/2015
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 08/2020
3	Hypertension (High Blood Pressure) 01/2022 - 01/2018
3	Neuroinflammatory Diseases 01/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 09/2014
3	Liver Neoplasms (Liver Cancer) 01/2020 - 12/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 10/2019 - 07/2009
3	Stomach Neoplasms (Stomach Cancer) 09/2019 - 01/2013
3	Lung Injury 03/2019 - 11/2009
3	Acute Lung Injury 03/2019 - 04/2011
3	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2016
3	Muscular Atrophy (Muscle Atrophy) 01/2016 - 07/2006
2	Mental Disorders (Mental Disorder) 07/2022 - 01/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 02/2021 - 06/2002
14	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2014
12	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
11	Biological ProductsIBA 01/2022 - 01/2017
9	CytokinesIBA 01/2021 - 01/2013
8	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2015
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2015
7	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2002
6	Long Noncoding RNAIBA 02/2021 - 12/2019
6	CopperIBA 01/2021 - 09/2004
6	CholesterolIBA 08/2020 - 01/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2016
5	Phosphotransferases (Kinase)IBA 02/2021 - 12/2017
5	Messenger RNA (mRNA)IBA 01/2021 - 04/2011
5	LuteinIBA 02/2014 - 12/2011
4	Triglycerides (Triacylglycerol)IBA 09/2022 - 10/2014
4	InflammasomesIBA 01/2021 - 01/2013
4	LactonesIBA 01/2021 - 12/2017
4	CollagenIBA 01/2021 - 01/2009
4	alantolactoneIBA 01/2021 - 12/2017
4	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 10/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 03/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2016
4	chan su (ChanSu)IBA 01/2020 - 11/2016
4	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 12/2019 - 10/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 10/2005
4	LipidsIBA 01/2016 - 04/2010
4	MicellesIBA 02/2011 - 07/2009
3	Oxygen (Dioxygen)IBA 02/2023 - 11/2014
3	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2020
3	PlatinumIBA 07/2022 - 07/2012
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2014
3	oxidized low density lipoproteinIBA 01/2022 - 08/2020
3	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2021 - 07/2006
3	NickelIBA 02/2021 - 09/2019
3	NucleotidesIBA 01/2021 - 09/2007
3	EnzymesIBA 01/2021 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2016
3	Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2011
3	Uric Acid (Urate)IBA 01/2021 - 11/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 09/2020 - 01/2012
3	SesquiterpenesIBA 09/2020 - 12/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2016
3	Peroxiredoxin VIIBA 03/2019 - 04/2011
3	Dopamine (Intropin)FDA LinkGeneric 10/2017 - 01/2017
3	Estrogens (Estrogen)FDA Link 10/2017 - 01/2016
3	LipopolysaccharidesIBA 09/2011 - 01/2009
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2011 - 06/2010
2	Capsules (Microcapsules)IBA 02/2023 - 12/2017
2	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 01/2018
2	GlycosyltransferasesIBA 07/2022 - 01/2022
2	LDL CholesterolIBA 01/2022 - 08/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2016
2	HDL CholesterolIBA 01/2022 - 08/2007

Therapy/Procedure

30	Therapeutics 01/2022 - 09/2004
11	Drug Therapy (Chemotherapy) 10/2022 - 01/2012
7	Immunotherapy 02/2023 - 01/2019
3	Percutaneous Coronary Intervention 02/2021 - 08/2020
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 09/2016
2	Segmental Mastectomy (Lumpectomy) 01/2022 - 10/2020